News | February 13, 2021
Steady performance; for Alkem Laboratories: ICICI Securities
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
The company continued to maintain clear FDA status across its plants and has received 12 ANDA approvals during 9MFY21
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
The medical device Sector in India suffers from a considerable cost of manufacturing disability.
This partnership is in line with the strategic focus of DKSH Business Unit Technology to solidify its position as a leading integrated solutions provider for the scientific Instrumentation market
Dr Christiane Hamacher, has stepped down as the MD of Biocon Biologics and will be succeeded by Dr Arun Chandavarkar.
Subscribe To Our Newsletter & Stay Updated
